2,204
Views
62
CrossRef citations to date
0
Altmetric
Research Paper

Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin

, , , , , & show all
Pages 586-592 | Received 30 Jan 2014, Accepted 09 Feb 2014, Published online: 20 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mikhail V. Blagosklonny. (2018) Rapamycin, proliferation and geroconversion to senescence. Cell Cycle 17:24, pages 2655-2665.
Read now
Komal Saraswat & Syed Ibrahim Rizvi. (2017) Novel strategies for anti-aging drug discovery. Expert Opinion on Drug Discovery 12:9, pages 955-966.
Read now
Olga V Leontieva, Geraldine M Paszkiewicz & Mikhail V Blagosklonny. (2014) Comparison of rapamycin schedules in mice on high-fat diet. Cell Cycle 13:21, pages 3350-3356.
Read now
Olga V Leontieva, Geraldine M Paszkiewicz & Mikhail V Blagosklonny. (2014) Fasting levels of hepatic p-S6 are increased in old mice. Cell Cycle 13:17, pages 2656-2659.
Read now

Articles from other publishers (58)

Zhibin Fu, Hailong XuLanping YueWeiwei ZhengLinkang PanFangyi GaoXingshan Liu. (2023) Immunosenescence and cancer: Opportunities and challenges. Medicine 102:47, pages e36045.
Crossref
Alessandro Bitto, Anthony S. Grillo, Takashi K. Ito, Ian B. Stanaway, Bao M. G. Nguyen, Kejun Ying, Herman Tung, Kaleb Smith, Ngoc Tran, Gunnar Velikanje, Silvan R. Urfer, Jessica M. Snyder, Jacob Barton, Ayush Sharma, Ernst-Bernhard Kayser, Lu Wang, Daniel L. SmithJr.Jr., J. Will Thompson, Laura DuBois, William DePaolo & Matt Kaeberlein. (2023) Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome. Nature Metabolism 5:6, pages 955-967.
Crossref
Tammi L. Kaeberlein, Alan S. Green, George Haddad, Johnny Hudson, Anar Isman, Andy Nyquist, Bradley S. Rosen, Yousin Suh, Sajad Zalzala, Xingyu Zhang, Mikhail V. Blagosklonny, Jonathan Y. An & Matt Kaeberlein. (2023) Evaluation of off-label rapamycin use to promote healthspan in 333 adults. GeroScience 45:5, pages 2757-2768.
Crossref
Joan B. Mannick & Dudley W. Lamming. (2023) Targeting the biology of aging with mTOR inhibitors. Nature Aging 3:6, pages 642-660.
Crossref
Mikhail V. Blagosklonny. (2023) Cancer prevention with rapamycin. Oncotarget 14:1, pages 342-350.
Crossref
Dudley W. Lamming. 2023. Anti-Aging Pharmacology. Anti-Aging Pharmacology 89 118 .
Jia Wei, Shuangmei Ye, Qian Chen, Milu Li, Weicheng Tang, Jinjin Zhang, Huan Lu, Yueyue Xi, Mingfu Wu, Ming Yuan, Dingfu Du, Jingyi Wen & Yan Zhang. 2023. Ovarian Aging. Ovarian Aging 253 288 .
Nikita Jinna, Padmashree Rida, Tianyi Su, Zhihong Gong, Song Yao, Mark LaBarge, Rama Natarajan, Tijana Jovanovic-Talisman, Christine Ambrosone & Victoria Seewaldt. (2022) The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations. Cells 11:23, pages 3818.
Crossref
M. Zaradzki, F. Mohr, S. Lont, J. Soethoff, A. Remes, R. Arif, O.J. Müller, M. Karck, M. Hecker & A.H. Wagner. (2022) Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome. Biochemical Pharmacology 205, pages 115280.
Crossref
Shailendra Kumar Mishra, Vyshnavy Balendra, Josephine Esposto, Ahmad A. Obaid, Ricardo B. Maccioni, Niraj Kumar Jha, George Perry, Mahmoud Moustafa, Mohammed Al-Shehri, Mahendra P. Singh, Anmar Anwar Khan, Emanuel Vamanu & Sandeep Kumar Singh. (2022) Therapeutic Antiaging Strategies. Biomedicines 10:10, pages 2515.
Crossref
Kirsten Seale, Steve Horvath, Andrew Teschendorff, Nir Eynon & Sarah Voisin. (2022) Making sense of the ageing methylome. Nature Reviews Genetics 23:10, pages 585-605.
Crossref
Bahareh Hassani, Ghazal Goshtasbi, Shirin Nooraddini & Negar Firouzabadi. (2022) Pharmacological Approaches to Decelerate Aging: A Promising Path. Oxidative Medicine and Cellular Longevity 2022, pages 1-25.
Crossref
Matthew J. Hagan, Robert Shenkar, Abhinav Srinath, Sharbel G. Romanos, Agnieszka Stadnik, Mark L. Kahn, Douglas A. Marchuk, Romuald Girard & Issam A. Awad. (2022) Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans. ACS Pharmacology & Translational Science 5:5, pages 266-277.
Crossref
Hyun Seung Lee & Heung-Woo Park. (2022) Role of mTOR in the Development of Asthma in Mice With Cigarette Smoke-Induced Cellular Senescence. The Journals of Gerontology: Series A 77:3, pages 433-442.
Crossref
Weiyi Shen, Jiamin He, Tongyao Hou, Jianmin Si & Shujie Chen. (2022) Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions. Aging and disease 13:4, pages 1063.
Crossref
Mikhail V. Blagosklonny. (2021) Anti-aging: senolytics or gerostatics (unconventional view). Oncotarget 12:18, pages 1821-1835.
Crossref
Ramasamy Selvarani, Sabira Mohammed & Arlan Richardson. (2020) Effect of rapamycin on aging and age-related diseases—past and future. GeroScience 43:3, pages 1135-1158.
Crossref
Murat KABAKLIOĞLU, Recep ERÖZ & Murat KAYA. (2021) Evaluation of the Effects of Rapamycin Treatment on Antioxidant Enzyme Changes and AgNOR in Testicular TorsionTestis Torsiyonunda Rapamisin Tedavisinin Antioksidan Enzim Değişiklikleri ve AgNOR Üzerindeki Etkilerinin Değerlendirilmesi. Konuralp Tıp Dergisi 13:1, pages 45-54.
Crossref
Niannian Ji, Neelam Mukherjee, Ryan M Reyes, Jonathan Gelfond, Martin Javors, Joshua J. Meeks, David J McConkey, Zhen-Ju Shu, Chethan Ramamurthy, Ryan Dennett, Tyler J Curiel & Robert S Svatek. (2021) Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study. Journal for ImmunoTherapy of Cancer 9:3, pages e001941.
Crossref
Mikhail V. Blagosklonny. (2021) DNA- and telomere-damage does not limit lifespan: evidence from rapamycin. Aging 13:3, pages 3167-3175.
Crossref
Mikhail V. Blagosklonny. (2021) The goal of geroscience is life extension. Oncotarget 12:3, pages 131-144.
Crossref
Evelyne Bischof, Richard C Siow, Alex Zhavoronkov & Matt Kaeberlein. (2021) The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19. The Lancet Healthy Longevity 2:2, pages e105-e111.
Crossref
Jingyao Lian, Ying Yue, Weina Yu & Yi Zhang. (2020) Immunosenescence: a key player in cancer development. Journal of Hematology & Oncology 13:1.
Crossref
Linda Partridge, Matias Fuentealba & Brian K. Kennedy. (2020) The quest to slow ageing through drug discovery. Nature Reviews Drug Discovery 19:8, pages 513-532.
Crossref
M. N. Yurova. (2020) The Use of Geroprotective Agents (mTOR Inhibitors) in the Treatment of Cancer Patients. Advances in Gerontology 10:3, pages 287-291.
Crossref
Andrey V. Panchenko, Margarita L. Tyndyk, Mikhail A. Maydin, Irina A. Baldueva, Anna S. Artemyeva, Stepan S. Kruglov, Galina S. Kireeva, Alexey G. Golubev, Alexey M. Belyaev & Vladimir N. Anisimov. (2020) Melatonin Administered before or after a Cytotoxic Drug Increases Mammary Cancer Stabilization Rates in HER2/Neu Mice. Chemotherapy 65:1-2, pages 42-50.
Crossref
Jin Young Lee, Brian K Kennedy & Chen-Yu Liao. (2020) Mechanistic target of rapamycin signaling in mouse models of accelerated aging. The Journals of Gerontology: Series A 75:1, pages 64-72.
Crossref
Greene Donald RoysterIVIV, Justine C. Harris, Amanda Nelson, Yessenia Castro, R. Patrick Weitzel, John Tisdale, Ryan J. Heitmann, Alan H. DeCherney & Erin F. Wolff. (2021) Rapamycin Corrects T Regulatory Cell Depletion and Improves Embryo Implantation and Live Birth Rates in a Murine Model. Reproductive Sciences 26:12, pages 1545-1556.
Crossref
Cong Fu, Yuhan Cao, Bing Li, Rongfeng Xu, Yuning Sun & Yuyu Yao. (2019) Bradykinin protects cardiac c‐kit positive cells from high‐glucose‐induced senescence through B2 receptor signaling pathway. Journal of Cellular Biochemistry 120:10, pages 17731-17743.
Crossref
Md. Saidul Islam, Yan Yan Jin, Hea-Jong Chung, Hyeon-Jin Kim, So-Hyeon Baek & Seong-Tshool Hong. (2019) Effect of the Resveratrol Rice DJ526 on Longevity. Nutrients 11:8, pages 1804.
Crossref
Duygu Dikicioglu, Elif Dereli Eke, Serpil Eraslan, Stephen G. Oliver & Betul Kirdar. (2018) Saccharomyces cerevisiae adapted to grow in the presence of low-dose rapamycin exhibit altered amino acid metabolism. Cell Communication and Signaling 16:1.
Crossref
Mikhail V. Blagosklonny. (2018) Disease or not, aging is easily treatable. Aging 10:11, pages 3067-3078.
Crossref
Alexey Golubev, Andrei Panchenko & Vladimir Anisimov. (2018) Applying parametric models to survival data: tradeoffs between statistical significance, biological plausibility, and common sense. Biogerontology 19:5, pages 341-365.
Crossref
Jin Liu, Dai-Chao Wu, Li-Hua Qu, Hong-Qing Liao & Mei-Xiang Li. (2018) The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging. Clinical Anatomy 31:6, pages 891-898.
Crossref
Jessica Lawrence & Richard Nho. (2018) The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis. International Journal of Molecular Sciences 19:3, pages 778.
Crossref
Mitchell B. Lee & Matt Kaeberlein. (2018) Translational geroscience: From invertebrate models to companion animal and human interventions. Translational Medicine of Aging 2, pages 15-29.
Crossref
Olga V. Leontieva & Mikhail V. Blagosklonny. (2017) While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts. Oncotarget 8:65, pages 109848-109856.
Crossref
Matt Kaeberlein. (2017) Translational geroscience: A new paradigm for 21st century medicine. Translational Medicine of Aging 1, pages 1-4.
Crossref
Takashi K. Ito, Chenhao Lu, Jacob Khan, Quy Nguyen, Heather Z. Huang, Dayae Kim, James Phillips, Jo Tan, Yenna Lee, Tuyet Nguyen, Samy Khessib, Natalie Lim, Surapat Mekvanich, Joshua Oh, Victor V. Pineda, Weirong Wang, Alessandro Bitto, Jonathan Y. An, John F. Morton, Mitsutoshi Setou, Warren C. Ladiges & Matt Kaeberlein. (2017) Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency. Frontiers in Genetics 8.
Crossref
Mitchell B. Lee, Daniel T. Carr, Michael G. Kiflezghi, Yan Ting Zhao, Deborah B. Kim, Socheata Thon, Margarete D. Moore, Mary Ann K. Li & Matt Kaeberlein. (2017) A system to identify inhibitors of mTOR signaling using high-resolution growth analysis in Saccharomyces cerevisiae. GeroScience 39:4, pages 419-428.
Crossref
Mikhail V. Blagosklonny. (2017) From rapalogs to anti-aging formula. Oncotarget 8:22, pages 35492-35507.
Crossref
Abel Soto-Gamez & Marco Demaria. (2017) Therapeutic interventions for aging: the case of cellular senescence. Drug Discovery Today 22:5, pages 786-795.
Crossref
Preety Bajwa, Sarah Nielsen, Janine M. Lombard, Loui Rassam, Pravin Nahar, Bo R. Rueda, J. Erby Wilkinson, Richard A. Miller & Pradeep S. Tanwar. (2016) Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice. Oncotarget 8:5, pages 7265-7275.
Crossref
Durgavati Yadav, Yamini B. Tripathi, Prabhakar Singh, Rajesh K. Kesharwani & Raj K. Keservani. 2017. Sustained Energy for Enhanced Human Functions and Activity. Sustained Energy for Enhanced Human Functions and Activity 31 51 .
Olga V. Leontieva & Mikhail V. Blagosklonny. (2016) Gerosuppression by pan-mTOR inhibitors. Aging 8:12, pages 3535-3551.
Crossref
Ivana Matic, Ajinkya Revandkar, Jingjing Chen, Angela Bisio, Stefano Dall’Acqua, Veronica Cocetta, Paola Brun, Giorgio Mancino, Martina Milanese, Maurizio Mattei, Monica Montopoli & Andrea Alimonti. (2016) Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay. Aging 8:12, pages 3223-3240.
Crossref
Loic Verlingue, Aurélien Dugourd, Gautier Stoll, Emmanuel Barillot, Laurence Calzone & Arturo Londoño‐Vallejo. (2016) A comprehensive approach to the molecular determinants of lifespan using a Boolean model of geroconversion. Aging Cell 15:6, pages 1018-1026.
Crossref
Matt Kaeberlein, Kate E. Creevy & Daniel E. L. Promislow. (2016) The dog aging project: translational geroscience in companion animals. Mammalian Genome 27:7-8, pages 279-288.
Crossref
Sebastian I. Arriola Apelo & Dudley W. Lamming. (2016) Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 71:7, pages 841-849.
Crossref
Sylvia Oghogho Iseghohi & Kingsley Omage. (2016) How ageing increases cancer susceptibility: A tale of two opposing yet synergistic views. Genes & Diseases 3:2, pages 105-109.
Crossref
Preety Bajwa, Prathima B. Nagendra, Sarah Nielsen, Subhransu S. Sahoo, Amanda Bielanowicz, Janine M. Lombard, J. Erby Wilkinson, Richard A. Miller & Pradeep S. Tanwar. (2016) Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium. Oncotarget 7:15, pages 19214-19227.
Crossref
Olga V. Leontieva, Zoya N. Demidenko & Mikhail V. Blagosklonny. (2015) Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program). Oncotarget 6:27, pages 23238-23248.
Crossref
Mikhail V. Blagosklonny. (2015) Rejuvenating immunity: “anti-aging drug today” eight years later. Oncotarget 6:23, pages 19405-19412.
Crossref
Timothy Nacarelli, Ashley Azar & Christian Sell. (2015) Aberrant mTOR activation in senescence and aging: A mitochondrial stress response?. Experimental Gerontology 68, pages 66-70.
Crossref
Chi V. Dang. (2015) A metabolic perspective of Peto's paradox and cancer. Philosophical Transactions of the Royal Society B: Biological Sciences 370:1673, pages 20140223.
Crossref
Lei Zhang, Nagarajarao Shamaladevi, Guddadarangavvanahally K. Jayaprakasha, Bhimu S. Patil & Bal L. Lokeshwar. (2015) Polyphenol-rich extract of Pimenta dioica berries (Allspice) kills breast cancer cells by autophagy and delays growth of triple negative breast cancer in athymic mice . Oncotarget 6:18, pages 16379-16395.
Crossref
Rebecca Lamb, Hannah Harrison, Duncan L. Smith, Paul A. Townsend, Thomas Jackson, Bela Ozsvari, Ubaldo E. Martinez-Outschoorn, Richard G. Pestell, Anthony Howell, Michael P. Lisanti & Federica Sotgia. (2015) Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction. Oncotarget 6:7, pages 4585-4601.
Crossref
M V Blagosklonny. (2014) Koschei the immortal and anti-aging drugs. Cell Death & Disease 5:12, pages e1552-e1552.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.